课题基金 / 基金详情

In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells

In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells
体外将体细胞重编程为多能 ES 样细胞
批准号:
8528901
负责人:
RUDOLF JAENISCH
金额:
$84.51万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-28 至 2018-05-31

项目摘要

项目成果

RUDOLF JAENISCH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A major focus of research for the next years will be to understand on a more detailed level the molecular mechanisms driving the reprogramming of somatic cells to pluripotent IPS cells. 1. Single-cell analysis of gene expression during cellular reprogramming An unresolved issue is whether activation of specific genes can predict early in the reprogramming process whether a given cell will develop into an iPS cell. Single RNA molecule detection methods will be Used to: a. assess whether a hierarchical program of gene expression leads to IPS cell formation or whether the process is entirely stochastic as suggested by previous observations. b. define markers that at early stages of reprogramming allow the prospective identification of cells that will generate IPS cells. For this, GFP will be inserted into candidate genes to give a marker for prospective isolation of IPS precursors. 2. Stoichiometry of reprogramming factors and quality of iPS cells mRNA mediated reprogramming will be used to systematically titrate the various factors for investigating the effect of factor stoichiometry on the biological properties of the IPS cells. This will allow the optimization of reprogramming with the goal of generating high quality genetically unmodified iPS cells. 3. Transdifferentiation of somatic cells to cells of different lineages Different somatic donor cells such as liver cells and skin keratinocytes will be used for direct conversion into neural precursors and neurons. Stringent reporters will allow the retrospective confirmation of the endodermal arid ectodermal donor cell type.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetically engineered human pluripotent stem cells as a platform to define the b
Transcriptional condensates, epigenetic editing and Rett Syndrome
Transcriptional condensates, epigenetic editing and Rett Syndrome
An iPSC based platform for functionally assessing genetic and environmental risk
海外基金